Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry-Reference-Cited by-同舟云学术

Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry

Published:2018-02 Issue: Volume:252 Page:169-174
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Gaertner S.,Cordeanu E.-M.,Mirea C.,Frantz A.-S.,Auger C.,Bilbault P.,Ohlmann P.,Schini-Kerth V.,Stephan D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. ESC guidelines on the diagnosis and management of acute pulmonary embolism;Konstantinides;Eur. Heart J.,2014

2. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study;Heit;Arch. Intern. Med.,2000

3. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale;Oger;Thromb. Haemost.,2000

4. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort;Tagalakis;Am. J. Med.,2013

5. The epidemiology of venous thromboembolism;White;Circulation,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous thrombosis and obesity: from clinical needs to therapeutic challenges;Internal and Emergency Medicine;2024-09-13

2. Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients;Arthritis & Rheumatology;2024-04-19

3. Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence;Journal of Thrombosis and Haemostasis;2023-05

4. Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism;Seminars in Thrombosis and Hemostasis;2022-10-17

5. Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case–time control study and a nested case-control study based on the French national health insurance (SNDS) cohort;BMJ Open;2022-09